- Why Do Oklahoma Sentent Repeat Drug Offenders to More Prison Time Then Someone Whos Commets Murder,Rapes,?
- How Do Drug Treatment Programs Help Society?
- Best Drug Rehab Center | Find the Best Drug Rehab Center Today
- Where Can I Find a Psychology Research Paper From a Scholarly Journal?
- Addiction
- Drug Addiction Treatment Center Newark NJ (855) 337-8500
- Constance Scharff, PhD: Developing Holistic, Integrated Approaches to Addiction Treatment
- How Do I Make My Essay More Descriptive?
- Do You Think Capital Punishment Is Right?
- NARCONON Georgia Drug Education.
- Drug Rehab Centers in Idaho | Call 800-303-2938 for More Information
- Intervention Centers Elgin | Drug Rehab Elgin | Intervention Centers Elgin
- Inpatient Drug Rehab Los Angeles (855) YES-REHAB
Medgenics Receives Orphan Drug Designation From FDA for …
Medgenics Receives Orphan Drug Designation from FDA for …
Filed under: drug treatment news stories
This marks the first Orphan Drug Designation granted for treatment of a clinical indication using the Biopump. Orphan …. Recent Stories from Medgenics, Inc.
Read more on EON: Enhanced Online News (press release)
Orexo Advances on Addiction Drug Study Result: Stockholm Mover
Filed under: drug treatment news stories
A dosage test on OX219, a treatment for opioid addiction, was finished … the reporter on this story: Janina Pfalzer in Stockholm at [email protected].
Read more on Bloomberg
Ryan Leaf sentenced to treatment for drugs
Filed under: drug treatment news stories
Former NFL quarterback Ryan Leaf could spend 15 months locked down in Montana, first in a secure drug treatment facility and then in a pre-release living …
Read more on WALA-TV FOX10
Medgenics, Inc. , the developer of BiopumpTM, a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that its INFRADURE™ Biopump has received Orphan Drug Designation from the U.S. … Read News
MISGAV, Israel & SAN FRANCISCO–(BUSINESS WIRE)–Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG), the developer of BiopumpTM, a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that its INFRADURE™ Biopump has received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) Office of Orphan … Read News